# Efficacy and Safety of Aliskiren Administered in Combination With Amlodipine Versus Amlodipine Alone in African American Patients With Stage 2 Hypertension

> **NCT00853957** · PHASE4 · COMPLETED · sponsor: **Novartis** · enrollment: 443 (actual)

## Conditions studied

- Hypertension

## Interventions

- **DRUG:** Aliskiren/Amlodipine
- **DRUG:** Amlodipine

## Key facts

- **NCT ID:** NCT00853957
- **Lead sponsor:** Novartis
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-02
- **Primary completion:** 2009-08
- **Final completion:** 2009-08
- **Target enrollment:** 443 (ACTUAL)
- **Last updated:** 2012-04-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00853957

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00853957, "Efficacy and Safety of Aliskiren Administered in Combination With Amlodipine Versus Amlodipine Alone in African American Patients With Stage 2 Hypertension". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00853957. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*